Literature DB >> 26205074

Frequency and topography of cerebral microbleeds in dementia with Lewy bodies compared to Alzheimer's disease.

Ipek Gungor1, Lidia Sarro2, Jonathan Graff-Radford3, Samantha M Zuk4, Nirubol Tosakulwong5, Scott A Przybelski5, Tim Lesnick5, Bradley F Boeve3, Tanis J Ferman6, Glenn E Smith7, David S Knopman3, Massimo Filippi8, Ronald C Petersen3, Clifford R Jack4, Kejal Kantarci9.   

Abstract

AIM: To determine the frequency and topographic distribution of cerebral microbleeds (CMBs) in dementia with Lewy bodies (DLB) in comparison to CMBs in Alzheimer disease dementia (AD).
METHODS: Consecutive probable DLB (n = 23) patients who underwent 3-T T2* weighted gradient-recalled-echo MRI, and age and gender matched probable Alzheimer's disease patients (n = 46) were compared for the frequency and location of CMBs.
RESULTS: The frequency of one or more CMBs was similar among patients with DLB (30%) and AD (24%). Highest densities of CMBs were found in the occipital lobes of patients with both DLB and AD. Patients with AD had greater densities of CMBs in the parietal, temporal lobes and infratentorial regions compared to DLB (p < 0.05).
CONCLUSION: CMBs are as common in patients with DLB as in patients with AD, with highest densities observed in the occipital lobes, suggesting common pathophysiologic mechanisms underlying CMBs in both diseases.
Copyright © 2015 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Alzheimer disease; Cerebral amyloid angiopathy; Cerebral microbleeds; Dementia with Lewy bodies; T2* weighted gradient-recalled-echo MRI

Mesh:

Year:  2015        PMID: 26205074      PMCID: PMC4554804          DOI: 10.1016/j.parkreldis.2015.07.008

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  20 in total

1.  Imaging of amyloid burden and distribution in cerebral amyloid angiopathy.

Authors:  Keith A Johnson; Matt Gregas; John A Becker; Catherine Kinnecom; David H Salat; Erin K Moran; Erin E Smith; Jonathan Rosand; Dorene M Rentz; William E Klunk; Chester A Mathis; Julie C Price; Steven T Dekosky; Alan J Fischman; Steven M Greenberg
Journal:  Ann Neurol       Date:  2007-09       Impact factor: 10.422

2.  Multimodality imaging characteristics of dementia with Lewy bodies.

Authors:  Kejal Kantarci; Val J Lowe; Bradley F Boeve; Stephen D Weigand; Matthew L Senjem; Scott A Przybelski; Dennis W Dickson; Joseph E Parisi; David S Knopman; Glenn E Smith; Tanis J Ferman; Ronald C Petersen; Clifford R Jack
Journal:  Neurobiol Aging       Date:  2011-10-21       Impact factor: 4.673

Review 3.  Amyloid-related imaging abnormalities in amyloid-modifying therapeutic trials: recommendations from the Alzheimer's Association Research Roundtable Workgroup.

Authors:  Reisa A Sperling; Clifford R Jack; Sandra E Black; Matthew P Frosch; Steven M Greenberg; Bradley T Hyman; Philip Scheltens; Maria C Carrillo; William Thies; Martin M Bednar; Ronald S Black; H Robert Brashear; Michael Grundman; Eric R Siemers; Howard H Feldman; Rachel J Schindler
Journal:  Alzheimers Dement       Date:  2011-07       Impact factor: 21.566

4.  Inflammatory cerebral amyloid angiopathy and amyloid-modifying therapies: variations on the same ARIA?

Authors:  David J Werring; Reisa Sperling
Journal:  Ann Neurol       Date:  2013-04       Impact factor: 10.422

5.  Focal hemosiderin deposits and β-amyloid load in the ADNI cohort.

Authors:  Kejal Kantarci; Jeffrey L Gunter; Nirubol Tosakulwong; Stephen D Weigand; Matthew S Senjem; Ronald C Petersen; Paul S Aisen; William J Jagust; Michael W Weiner; Clifford R Jack
Journal:  Alzheimers Dement       Date:  2013-01-30       Impact factor: 21.566

6.  Prevalence and clinicoradiological analyses of patients with Alzheimer disease coexisting multiple microbleeds.

Authors:  Junpei Nagasawa; Tetsuhito Kiyozaka; Ken Ikeda
Journal:  J Stroke Cerebrovasc Dis       Date:  2014-08-28       Impact factor: 2.136

7.  Microbleed topography, leukoaraiosis, and cognition in probable Alzheimer disease from the Sunnybrook dementia study.

Authors:  Jacqueline A Pettersen; Gayathri Sathiyamoorthy; Fu-Qiang Gao; Gregory Szilagyi; Neelesh K Nadkarni; Peter St George-Hyslop; Ekaterina Rogaeva; Sandra E Black
Journal:  Arch Neurol       Date:  2008-06

8.  Prevalence and risk factors of cerebral microbleeds: the Rotterdam Scan Study.

Authors:  M W Vernooij; A van der Lugt; M A Ikram; P A Wielopolski; W J Niessen; A Hofman; G P Krestin; M M B Breteler
Journal:  Neurology       Date:  2008-04-01       Impact factor: 9.910

9.  In vivo amyloid imaging in autopsy-confirmed Parkinson disease with dementia.

Authors:  M A Burack; J Hartlein; H P Flores; L Taylor-Reinwald; J S Perlmutter; N J Cairns
Journal:  Neurology       Date:  2010-01-05       Impact factor: 9.910

10.  Amyloid-related imaging abnormalities in patients with Alzheimer's disease treated with bapineuzumab: a retrospective analysis.

Authors:  Reisa Sperling; Stephen Salloway; David J Brooks; Donatella Tampieri; Jerome Barakos; Nick C Fox; Murray Raskind; Marwan Sabbagh; Lawrence S Honig; Anton P Porsteinsson; Ivan Lieberburg; H Michael Arrighi; Kristen A Morris; Yuan Lu; Enchi Liu; Keith M Gregg; H Robert Brashear; Gene G Kinney; Ronald Black; Michael Grundman
Journal:  Lancet Neurol       Date:  2012-02-03       Impact factor: 44.182

View more
  7 in total

Review 1.  Dementia with Lewy bodies and Parkinson's disease-dementia: current concepts and controversies.

Authors:  Kurt A Jellinger
Journal:  J Neural Transm (Vienna)       Date:  2017-12-08       Impact factor: 3.575

2.  Significance of cerebral amyloid angiopathy and other co-morbidities in Lewy body diseases.

Authors:  Kurt A Jellinger
Journal:  J Neural Transm (Vienna)       Date:  2021-04-29       Impact factor: 3.575

Review 3.  Blood-brain barrier leakage in Alzheimer's disease: From discovery to clinical relevance.

Authors:  Geetika Nehra; Bjoern Bauer; Anika M S Hartz
Journal:  Pharmacol Ther       Date:  2022-01-30       Impact factor: 13.400

4.  Difference in the Location and Risk Factors of Cerebral Microbleeds According to Ischemic Stroke Subtypes.

Authors:  Bum Joon Kim; Youngshin Yoon; Hoyon Sohn; Dong-Wha Kang; Jong S Kim; Sun U Kwon
Journal:  J Stroke       Date:  2016-09-30       Impact factor: 6.967

5.  Are dementia with Lewy bodies and Parkinson's disease dementia the same disease?

Authors:  Kurt A Jellinger; Amos D Korczyn
Journal:  BMC Med       Date:  2018-03-06       Impact factor: 8.775

6.  Microbleeds in dementia with Lewy bodies.

Authors:  Paul C Donaghy; Michael Firbank; Dipayan Mitra; George Petrides; Jim Lloyd; Nicola Barnett; Kirsty Olsen; Alan J Thomas; John T O'Brien
Journal:  J Neurol       Date:  2020-02-04       Impact factor: 4.849

7.  Clinical impact of microbleeds in patients with Alzheimer's disease.

Authors:  Daniel Vázquez-Justes; Iván Aguirregoicoa; Leandre Fernandez; Anna Carnes-Vendrell; Faride Dakterzada; Laura Sanjuan; Andreu Mena; Gerard Piñol-Ripoll
Journal:  BMC Geriatr       Date:  2022-09-29       Impact factor: 4.070

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.